These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 32972983)

  • 21. Identification of Celastramycin as a Novel Therapeutic Agent for Pulmonary Arterial Hypertension.
    Kurosawa R; Satoh K; Kikuchi N; Kikuchi H; Saigusa D; Al-Mamun ME; Siddique MAH; Omura J; Satoh T; Sunamura S; Nogi M; Numano K; Miyata S; Uruno A; Kano K; Matsumoto Y; Doi T; Aoki J; Oshima Y; Yamamoto M; Shimokawa H
    Circ Res; 2019 Jul; 125(3):309-327. PubMed ID: 31195886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contribution of Impaired Parasympathetic Activity to Right Ventricular Dysfunction and Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension.
    da Silva Gonçalves Bós D; Van Der Bruggen CEE; Kurakula K; Sun XQ; Casali KR; Casali AG; Rol N; Szulcek R; Dos Remedios C; Guignabert C; Tu L; Dorfmüller P; Humbert M; Wijnker PJM; Kuster DWD; van der Velden J; Goumans MJ; Bogaard HJ; Vonk-Noordegraaf A; de Man FS; Handoko ML
    Circulation; 2018 Feb; 137(9):910-924. PubMed ID: 29167228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenotypically Silent Bone Morphogenetic Protein Receptor 2 Mutations Predispose Rats to Inflammation-Induced Pulmonary Arterial Hypertension by Enhancing the Risk for Neointimal Transformation.
    Tian W; Jiang X; Sung YK; Shuffle E; Wu TH; Kao PN; Tu AB; Dorfmüller P; Cao A; Wang L; Peng G; Kim Y; Zhang P; Chappell J; Pasupneti S; Dahms P; Maguire P; Chaib H; Zamanian R; Peters-Golden M; Snyder MP; Voelkel NF; Humbert M; Rabinovitch M; Nicolls MR
    Circulation; 2019 Oct; 140(17):1409-1425. PubMed ID: 31462075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maresin 1 intervention reverses experimental pulmonary arterial hypertension in mice.
    Li H; Li X; Hao Y; Wu C; Fu Y; Su N; Chen H; Ying B; Wang H; Su L; Cai H; He Q; Cai M; Sun J; Lin J; Scott A; Smith F; Huang X; Jin S
    Br J Pharmacol; 2022 Nov; 179(22):5132-5147. PubMed ID: 35764296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting RUNX1 as a novel treatment modality for pulmonary arterial hypertension.
    Jeong EM; Pereira M; So EY; Wu KQ; Del Tatto M; Wen S; Dooner MS; Dubielecka PM; Reginato AM; Ventetuolo CE; Quesenberry PJ; Klinger JR; Liang OD
    Cardiovasc Res; 2022 Dec; 118(16):3211-3224. PubMed ID: 35018410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabotropic glutamate receptor 5 blockade attenuates pathological cardiac remodelling in pulmonary arterial hypertension.
    Mprah R; Ma Y; Adzika GK; Ndzie Noah ML; Adekunle AO; Duah M; Adu-Amankwaah J; Wowui PI; Okwuma JD; Qiao W; Wang C
    Clin Exp Pharmacol Physiol; 2022 May; 49(5):558-566. PubMed ID: 35133684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dapagliflozin, sildenafil and their combination in monocrotaline-induced pulmonary arterial hypertension.
    Tang Y; Tan S; Li M; Tang Y; Xu X; Zhang Q; Fu Q; Tang M; He J; Zhang Y; Zheng Z; Peng J; Zhu T; Xie W
    BMC Pulm Med; 2022 Apr; 22(1):142. PubMed ID: 35413880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum and pulmonary uric acid in pulmonary arterial hypertension.
    Savale L; Akagi S; Tu L; Cumont A; Thuillet R; Phan C; Le Vely B; Berrebeh N; Huertas A; Jaïs X; Cottin V; Chaouat A; Tromeur C; Boucly A; Jutant EM; Mercier O; Fadel E; Montani D; Sitbon O; Humbert M; Tamura Y; Guignabert C
    Eur Respir J; 2021 Aug; 58(2):. PubMed ID: 33446602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Notch2 suppression mimicking changes in human pulmonary hypertension modulates Notch1 and promotes endothelial cell proliferation.
    Sahoo S; Li Y; de Jesus D; Sembrat J; Rojas MM; Goncharova E; Cifuentes-Pagano E; Straub AC; Pagano PJ
    Am J Physiol Heart Circ Physiol; 2021 Sep; 321(3):H542-H557. PubMed ID: 34296965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Farnesyl diphosphate synthase regulated endothelial proliferation and autophagy during rat pulmonary arterial hypertension induced by monocrotaline.
    Jin T; Lu J; Lv Q; Gong Y; Feng Z; Ying H; Wang M; Fu G; Jiang D
    Mol Med; 2022 Aug; 28(1):94. PubMed ID: 35962329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ASK1 Inhibition Halts Disease Progression in Preclinical Models of Pulmonary Arterial Hypertension.
    Budas GR; Boehm M; Kojonazarov B; Viswanathan G; Tian X; Veeroju S; Novoyatleva T; Grimminger F; Hinojosa-Kirschenbaum F; Ghofrani HA; Weissmann N; Seeger W; Liles JT; Schermuly RT
    Am J Respir Crit Care Med; 2018 Feb; 197(3):373-385. PubMed ID: 28910144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension.
    Behringer A; Trappiel M; Berghausen EM; Ten Freyhaus H; Wellnhofer E; Odenthal M; Blaschke F; Er F; Gassanov N; Rosenkranz S; Baldus S; Kappert K; Caglayan E
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):369-79. PubMed ID: 26742933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sulforaphane prevents right ventricular injury and reduces pulmonary vascular remodeling in pulmonary arterial hypertension.
    Kang Y; Zhang G; Huang EC; Huang J; Cai J; Cai L; Wang S; Keller BB
    Am J Physiol Heart Circ Physiol; 2020 Apr; 318(4):H853-H866. PubMed ID: 32108526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neutralization of CXCL12 attenuates established pulmonary hypertension in rats.
    Bordenave J; Thuillet R; Tu L; Phan C; Cumont A; Marsol C; Huertas A; Savale L; Hibert M; Galzi JL; Bonnet D; Humbert M; Frossard N; Guignabert C
    Cardiovasc Res; 2020 Mar; 116(3):686-697. PubMed ID: 31173066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nintedanib improves cardiac fibrosis but leaves pulmonary vascular remodelling unaltered in experimental pulmonary hypertension.
    Rol N; de Raaf MA; Sun XQ; Kuiper VP; da Silva Gonçalves Bos D; Happé C; Kurakula K; Dickhoff C; Thuillet R; Tu L; Guignabert C; Schalij I; Lodder K; Pan X; Herrmann FE; van Nieuw Amerongen GP; Koolwijk P; Vonk-Noordegraaf A; de Man FS; Wollin L; Goumans MJ; Szulcek R; Bogaard HJ
    Cardiovasc Res; 2019 Feb; 115(2):432-439. PubMed ID: 30032282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endothelial Krüppel-like factor 4 modulates pulmonary arterial hypertension.
    Shatat MA; Tian H; Zhang R; Tandon G; Hale A; Fritz JS; Zhou G; Martínez-González J; Rodríguez C; Champion HC; Jain MK; Hamik A
    Am J Respir Cell Mol Biol; 2014 Mar; 50(3):647-53. PubMed ID: 24156273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of the Aryl Hydrocarbon Receptor in Sugen 5416-induced Experimental Pulmonary Hypertension.
    Dean A; Gregorc T; Docherty CK; Harvey KY; Nilsen M; Morrell NW; MacLean MR
    Am J Respir Cell Mol Biol; 2018 Mar; 58(3):320-330. PubMed ID: 28956952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potassium Channel Subfamily K Member 3 (KCNK3) Contributes to the Development of Pulmonary Arterial Hypertension.
    Antigny F; Hautefort A; Meloche J; Belacel-Ouari M; Manoury B; Rucker-Martin C; Péchoux C; Potus F; Nadeau V; Tremblay E; Ruffenach G; Bourgeois A; Dorfmüller P; Breuils-Bonnet S; Fadel E; Ranchoux B; Jourdon P; Girerd B; Montani D; Provencher S; Bonnet S; Simonneau G; Humbert M; Perros F
    Circulation; 2016 Apr; 133(14):1371-85. PubMed ID: 26912814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel assessment of haemodynamic kinetics with acute exercise in a rat model of pulmonary arterial hypertension.
    Brown MB; Chingombe TJ; Zinn AB; Reddy JG; Novack RA; Cooney SA; Fisher AJ; Presson RG; Lahm T; Petrache I
    Exp Physiol; 2015 Jun; 100(6):742-54. PubMed ID: 25867528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibiting IL-6 in medicine: a new twist to sustain inhibition of his cytokine tin the therapy of Pulmonary Arterial Hypertension.
    Gugliandolo E; Macrì F; Fusco R; Siracusa R; Cordaro M; D'amico R; Peritore AF; Impellizzeri D; Genovese T; Cuzzocrea S; Di Paola R; Crupi R
    Pharmacol Res; 2023 Jun; 192():106750. PubMed ID: 37004831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.